| Dear customer, |
| Recent studies scrutinizing the main players in our organism’s immune response to COVID-19 have revealed unexpected similarities between cancer and the new respiratory disease. |
| In COVID-19 patients with severe pneumonia and acute respiratory distress syndrome (ARDS), the lung damage-causing culprits could be the same molecules known to make our immune system powerless against cancer cells. |
| Despite increasing the complexity of the new disease, these studies also point out a new direction in the development of effective COVID-19 treatments. |
| In this article we will explore: |
- The parallelism between our organism’s response to cancer and COVID-19
- The key immune checkpoint targets in COVID-19
- The immune checkpoint inhibitors currently in clinical trials for the treatment of COVID-19
|
| Read the complete article on our website. |
| Best regards, |
Philippe Funfrock
CEO
ProteoGenix |
| Unsubscribe |
